At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 392 enrolled
Drug / intervention
Tramadol Once A Daydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee
In Brief
A Phase 3 clinical trial evaluating Tramadol Once A Day for Osteoarthritis, Knee. Completed, enrolled 392 participants.
Detailed Summary
The purpose of this study is to collect information regarding the long-term (6 and 12 months) safety of Tramadol HCl Once-A-Day(OAD) 300 mg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2003
Primary CompletionJul 2004
First PostedFeb 2009
TodayJul 2026
First PostedFeb 2, 2009
Enrollment StartApr 1, 2003
Primary CompletionJul 1, 2004
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.4 years ago
Interventions
Tramadol Once A Daydrug